- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
- You can view the full Microsoft Ratings Report.
- You can view the full Pfizer Ratings Report.
IBM's fourth quarter could show a continued turnaround, due in large part to growth in its strategic imperatives. Here are three ETFs that may benefit if that comes to fruition.
Artificial intelligence is crucial to the Chinese search giant's future.